Schedule 13D ownership disclosure

COMPASS PATHWAYS PLC SPONSORED ADS

Security class unavailable · CUSIP: 20451W101

Event date: 2023-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,519,361
Percent of class
11.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001628280-23-005044
Form type
SC 13D
Filer
Mineralys Therapeutics, Inc.
CIK
CIK 1933414
Filed
Feb 24, 2023
Reporting period
Feb 14, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub